MicroRNAs Regulate Human Hepatocyte Nuclear Factor 4alpha, Modulating the Expression of Metabolic Enzymes and Cell Cycle

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Dec 19

PMID 20018894

Citations 75

Authors

Shingo Takagi

Miki Nakajima

Katsuhiko Kida

Yu Yamaura

Tatsuki Fukami

Tsuyoshi Yokoi

Affiliations

Soon will be listed here.

Abstract

Hepatocyte nuclear factor (HNF) 4alpha is a key transcription factor regulating endo/xenobiotic-metabolizing enzymes and transporters. We investigated whether microRNAs are involved in the regulation of human HNF4alpha. Potential recognition elements for miR-24 (MRE24) were identified in the coding region and the 3'-untranslated region (3'-UTR), and those for miR-34a (MRE34a) were identified in the 3'-UTR in HNF4alpha mRNA. The HNF4alpha protein level in HepG2 cells was markedly decreased by the overexpression of miR-24 and miR-34a. The HNF4alpha mRNA level was significantly decreased by the overexpression of miR-24 but not by miR-34a. In luciferase analyses in HEK293 cells, the reporter activity of plasmid containing the 3'-UTR of HNF4alpha was significantly decreased by miR-34a. The reporter activity of plasmid containing the HNF4alpha coding region downstream of the luciferase gene was significantly decreased by miR-24. These results suggest that the MRE24 in the coding region and MRE34a in the 3'-UTR are functional in the negative regulation by mRNA degradation and translational repression, respectively. The down-regulation of HNF4alpha by these microRNAs resulted in the decrease of various target genes such as cytochrome P450 7A1 and 8B1 as well as morphological changes and the decrease of the S phase population in HepG2 cells. We also clarified that the expressions of miR-24 and miR-34a were regulated by protein kinase C/mitogen-activated protein kinase and reactive oxygen species pathways, respectively. In conclusion, we found that human HNF4alpha was down-regulated by miR-24 and miR-34a, the expression of which are regulated by cellular stress, affecting the metabolism and cellular biology.

Citing Articles

Pharmacokinetics, Pharmacodynamics, and Side Effects of Midazolam: A Review and Case Example.

Peter J, Dieudonne P, Zolk O Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675433 PMC: 11054797. DOI: 10.3390/ph17040473.

Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.

Le M, Nguyen H, Nguyen X, Do X, Mai B, Ngoc Nguyen H Heliyon. 2023; 9(11):e22080.

PMID: 38058618 PMC: 10696070. DOI: 10.1016/j.heliyon.2023.e22080.

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.

Hussen B, Rasul M, Abdullah S, Hidayat H, Faraj G, Ali F Mil Med Res. 2023; 10(1):32.

PMID: 37460924 PMC: 10351202. DOI: 10.1186/s40779-023-00468-6.

Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition.

Tu M, Yu A Curr Drug Metab. 2023; 24(3):175-189.

PMID: 37170982 PMC: 10825985. DOI: 10.2174/1389200224666230425232433.

Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis.

Goldman O, Adler L, Hajaj E, Croese T, Darzi N, Galai S Cancer Discov. 2023; 13(7):1616-1635.

PMID: 36972357 PMC: 10326600. DOI: 10.1158/2159-8290.CD-22-1062.

References

Hylemon P, Zhou H, Pandak W, Ren S, Gil G, Dent P . Bile acids as regulatory molecules. J Lipid Res. 2009; 50(8):1509-20. PMC: 2724047. DOI: 10.1194/jlr.R900007-JLR200. View

Chang T, Wentzel E, Kent O, Ramachandran K, Mullendore M, Lee K . Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007; 26(5):745-52. PMC: 1939978. DOI: 10.1016/j.molcel.2007.05.010. View

Gonzalez F . Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet. 2008; 23(1):2-7. DOI: 10.2133/dmpk.23.2. View

Parviz F, Matullo C, Garrison W, Savatski L, Adamson J, Ning G . Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet. 2003; 34(3):292-6. DOI: 10.1038/ng1175. View

Hatzis P, Kyrmizi I, Talianidis I . Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression. Mol Cell Biol. 2006; 26(19):7017-29. PMC: 1592892. DOI: 10.1128/MCB.00297-06. View

Goodwin B, Jones S, Price R, Watson M, McKee D, Moore L . A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 2000; 6(3):517-26. DOI: 10.1016/s1097-2765(00)00051-4. View

Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z . Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 2008; 123(4):972-8. DOI: 10.1002/ijc.23580. View

Lee Y, Dell H, Dowhan D, Moore D . The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression. Mol Cell Biol. 1999; 20(1):187-95. PMC: 85074. DOI: 10.1128/MCB.20.1.187-195.2000. View

Tay Y, Zhang J, Thomson A, Lim B, Rigoutsos I . MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008; 455(7216):1124-8. DOI: 10.1038/nature07299. View

10.

Battle M, Konopka G, Parviz F, Gaggl A, Yang C, Sladek F . Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci U S A. 2006; 103(22):8419-24. PMC: 1482507. DOI: 10.1073/pnas.0600246103. View

11.

Stanger B . HNF4A and diabetes: injury before insult?. Diabetes. 2008; 57(6):1461-2. DOI: 10.2337/db08-0454. View

12.

Krutzfeldt J, Rajewsky N, Braich R, Rajeev K, Tuschl T, Manoharan M . Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. DOI: 10.1038/nature04303. View

13.

Yue H, Yin C, Hou J, Zeng X, Chen Y, Zhong W . Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut. 2009; 59(2):236-46. DOI: 10.1136/gut.2008.174904. View

14.

Forman J, Legesse-Miller A, Coller H . A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A. 2008; 105(39):14879-84. PMC: 2567461. DOI: 10.1073/pnas.0803230105. View

15.

Day C . Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?. Gut. 2002; 50(5):585-8. PMC: 1773193. DOI: 10.1136/gut.50.5.585. View

16.

Li T, Jahan A, Chiang J . Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Hepatology. 2006; 43(6):1202-10. PMC: 1526464. DOI: 10.1002/hep.21183. View

17.

Guo H, Gao C, Mi Z, Wai P, Kuo P . Phosphorylation of Ser158 regulates inflammatory redox-dependent hepatocyte nuclear factor-4alpha transcriptional activity. Biochem J. 2005; 394(Pt 2):379-87. PMC: 1482807. DOI: 10.1042/BJ20051730. View

18.

Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia M . miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2006; 1(2):106-13. DOI: 10.4161/rna.1.2.1066. View

19.

Hand N, Master Z, Le Lay J, Friedman J . Hepatic function is preserved in the absence of mature microRNAs. Hepatology. 2009; 49(2):618-26. PMC: 2635423. DOI: 10.1002/hep.22656. View

20.

Lytle J, Yario T, Steitz J . Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A. 2007; 104(23):9667-72. PMC: 1887587. DOI: 10.1073/pnas.0703820104. View